Delivery Order SPE2DR25D3303-SPE2DR26F66A9
Award Date 1/20/26
Potential Completion Date 1/21/26
Potential Value $4.3K
Federal Agency
Awardee
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Defense Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 25, 2025, for the supply of Entecavir 0.5 mg tablets in quantities of 30 units, with a contract ceiling value of $4,809.12. This firm fixed-price delivery order, with an ultimate completion date of September 26, 2025, represents a non-competitive set-aside award and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under...
- The Defense Logistics Agency awarded a delivery order valued at $5,084.36 to AmerisourceBergen Drug Corp for 30 tablets of Entecavir 0.5 mg, an antiviral medication used to treat hepatitis B. This competitively awarded, firm fixed-price delivery order was issued on October 24, 2025, with an ultimate completion date of October 27, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Entecavir 0.5 mg tablets in a 30-count quantity, with a contract ceiling value of $1,120.22. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, is being fulfilled from the vendor's corporate office located in Conshohocken, Pennsylvania. The award represents a competitive procurement with no set-aside designation and is executed as a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Entecavir 0.5 mg tablets in a quantity of 30 units. This firm fixed price delivery order, valued at $2,881.89, was competitively awarded without set-aside designation and is scheduled for completion by August 4, 2025. The contract leverages AmerisourceBergen's significant Indefinite Delivery Contract (IDC) with DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $11,939.50 firm fixed-price delivery order is for the supply of Entecavir 0.5 mg tablets, a medication used to treat chronic hepatitis B. The contract has an ultimate completion date of May 7, 2024. Amerisourcebergen is a major pharmaceutical distributor that serves as a key vendor for federal healthcare programs, particularly for the...
- The Defense Logistics Agency awarded a delivery order valued at $1,774.43 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count packages) on August 18, 2025, with completion scheduled for August 19, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical procurement executed under a non-set-aside designation. The award is performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a $1,574.55 firm fixed-price delivery order to AmerisourceBergen Drug Corp (UEI: KABZK8W6PQT3) on January 16, 2026, for the supply of Entecavir 0.5 mg tablets (30-count units), with completion scheduled for January 20, 2026. The contract was awarded on a non-set-aside, competitive basis to the vendor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen),...
- The Defense Logistics Agency awarded a delivery order valued at $5,583.57 to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count units) on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Entecavir 0.5 mg tablets (30-count package) with a ceiling value of $1,337.46. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025, to be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was not designated as a set-aside contract, indicating it was competitively awarded through open...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Entecavir 0.5 mg tablets (30-count package) with a ceiling value of $1,335.97. The contract was awarded on November 17, 2025, with an ultimate completion date of November 18, 2025, and is structured as a firm fixed-price delivery order with no set-aside designation. This award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...